1. HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach
LONDON 2015

2. LJWG Overview
Chair: Dr Ashley Brown Consultant Hepatologist, St Mary’s and Hammersmith Hospitals London Honorary Senior Lecturer, Imperial College London

3. Why we exist – lack of joined-up care meaning that people can’t access treatment
This graphic taken from our original London Consensus 2011, since updated

4. LJWG MISSION: To eliminate hepatitis C in drug users,
and those engaged in drug services in London

7. LJWG Dr Kosh Agarwal Charles Gore Dr Ashley Brown Professor David Nutt
Scientific Steering Committee
Dr Kosh Agarwal
Charles Gore
Dr Ashley Brown
Professor David Nutt
Janet Catt
Dr Magdalena Harris
Dr Emily Finch
Dr Mike Kelleher
Professor Graham Foster
Professor William Rosenberg
PARTNER ORGANISATIONS:
PHARMA COMPANY STAKEHOLDERS: AbbVie, MSD, Gilead Sciences and Janssen

8. #LJWG2015